{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:11:42Z","timestamp":1783606302607,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Mount Sinai Hospital\/University Health Network Research Grant"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ygyno.2014.02.020","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T20:45:21Z","timestamp":1392756321000},"page":"229-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6020-3075","authenticated-orcid":false,"given":"Andrea N.","family":"Simpson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Feigenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian T.","family":"Gien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ismiil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Laframboise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ygyno.2014.02.020_bb0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-0412.2012.01438.x","article-title":"Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey","volume":"91","author":"Lajer","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.ygyno.2014.02.020_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.02.020_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bpobgyn.2008.11.010","article-title":"Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer","volume":"24","author":"Papaioannou","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"10.1016\/j.ygyno.2014.02.020_bb0020","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/cncr.21866","article-title":"Association between adiponectin, insulin resistance, and endometrial cancer","volume":"106","author":"Soliman","year":"2006","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2014.02.020_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/OGX.0b013e31822f8f66","article-title":"Fertility-sparing management of endometrial adenocarcinoma","volume":"66","author":"Dorais","year":"2011","journal-title":"Obstet Gynecol Surv"},{"issue":"6","key":"10.1016\/j.ygyno.2014.02.020_bb0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1827.2004.01644.x","article-title":"Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation","volume":"54","author":"Yasuda","year":"2004","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.ygyno.2014.02.020_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2005.05.025","article-title":"Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report","volume":"99","author":"Ferrandina","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.02.020_bb0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/ijgc-00009577-200507000-00012","article-title":"Clinicopathologic study of uterine endometrial carcinoma in young women aged 40years and younger","volume":"15","author":"Ota","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2014.02.020_bb0045","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1525-1438.2006.00730.x","article-title":"A rare case of choroidal metastasis presented after conservative management of endometrial cancer","volume":"16","author":"Cormio","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2014.02.020_bb0050","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.02.020_bb0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.1996.14.2.357","article-title":"High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"14","author":"Lentz","year":"1996","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.02.020_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.ygyno.2014.02.020_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09513590902733733","article-title":"The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.02.020_bb0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.11.004","article-title":"Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy","volume":"124","author":"Penner","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.02.020_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2012.12.037","article-title":"Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin","volume":"129","author":"Park","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ygyno.2014.02.020_bb0080","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/IGC.0b013e31826302a3","article-title":"Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples","volume":"22","author":"Robbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2014.02.020_bb0085","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2014.02.020_bb0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.02.020_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/IGC.0b013e31819c5372","article-title":"Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients","volume":"19","author":"Eftekhar","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.02.020_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/IGC.0b013e31819960ba","article-title":"Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia","volume":"19","author":"Han","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2014.02.020_bb0105","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/humrep\/dem088","article-title":"Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer","volume":"22","author":"Yamazawa","year":"2007","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ygyno.2014.02.020_bb0110","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/PAS.0b013e3181bc9866","article-title":"Endometrial carcinomas in women aged 40years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.02.020_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004347-200304000-00005","article-title":"Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia","volume":"22","author":"Orbo","year":"2003","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.ygyno.2014.02.020_bb0120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.02.020_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ygyno.2014.02.020_bb0130","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/IGC.0b013e3181e94f5a","article-title":"Fertility-sparing therapy in young women with endometrial cancer: 2010 update","volume":"20","author":"Erkanli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.02.020_bb0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2 Suppl.","key":"10.1016\/j.ygyno.2014.02.020_bb0140","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ygyno.2008.07.056","article-title":"Sparing fertility in young patients with endometrial cancer","volume":"111","author":"Chiva","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.02.020_bb0145","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.02.020_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2013.02.031","article-title":"Fertility preserving treatments for endometrial cancer: the unanswered questions","volume":"129","author":"Gotlieb","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.02.020_bb0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.02.020_bb0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0029-7844(95)00001-8","article-title":"Endometrial cancer in premenopausal women 45years and younger","volume":"85","author":"Gitsch","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"22","key":"10.1016\/j.ygyno.2014.02.020_bb0165","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2014.02.020_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jnci\/djp473","article-title":"Risks of Lynch syndrome cancers for MSH6 mutation carriers","volume":"102","author":"Baglietto","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ygyno.2014.02.020_bb0175","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijgo.2012.06.010","article-title":"A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer","volume":"119","author":"Dursun","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.ygyno.2014.02.020_bb0180","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.ajog.2013.11.001","article-title":"Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma","volume":"210","author":"Kudesia","year":"2014","journal-title":"Am J Obstet Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:34:57Z","timestamp":1758771297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0090825814001383"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}